Huber J, Hallscheidt P, Wagener N, Pahernik S, Haferkamp A, Hohenfellner M
Urologische Klinik und Poliklinik, Universität Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg.
Urologe A. 2010 Mar;49(3):345-50. doi: 10.1007/s00120-010-2269-9.
Because of progress in imaging, the incidence of renal tumours, especially small lesions, has been rising over the last years. Therefore, imaging must be done to decide how to proceed further. But which is the most effective modality: computed tomography (CT) or magnetic resonance imaging (MRI)? From the technical point of view, the two alternatives appear to be nearly equal. Multidetector CT remains the reference standard for staging and lesion characterisation, whereas MRI is the method of choice for determining caval extension of a tumour thrombus and infiltration of the renal vein. If an accurate diagnosis cannot be specified, the remaining modality should be used complementarily.
由于成像技术的进步，近年来肾肿瘤尤其是小病灶的发病率一直在上升。因此，必须进行成像检查以决定后续的处理方式。但哪种方式最有效：计算机断层扫描（CT）还是磁共振成像（MRI）？从技术角度来看，这两种选择似乎几乎相当。多排CT仍然是分期和病灶特征描述的参考标准，而MRI是确定肿瘤血栓的腔静脉延伸和肾静脉浸润的首选方法。如果无法明确做出准确诊断，则应补充使用另一种方式。
